ASMA LATIF (M.D.) – Hematology & Oncology Physician, NPI 1013133560
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
606 HEMATOLOGY/ONCOLOGY in MA
Provider Addresses for ASMA LATIF (M.D.)
19 STURDY ST
ATTLEBORO, MA 027033193
Phone: (508) 236-8525
Fax: (508) 342-1927
Type: Location
450 Brookline Ave
Boston, MA 022155450
Phone: (617) 632-6140
Fax: (617) 632-3000
Type: Location
1275 YORK AVE
NEW YORK, NY 100656007
Phone:
Type: Mailing
28 STURDY ST
ATTLEBORO, MA 027033148
Phone: (508) 236-8525
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 14 Open Payments records for all available years, with a total value of $801.
Total Amount is formed as General ($801) + Research ($0) + Ownership ($0) = $801.
Last reported payment date: 2024-06-13 • Largest payer in this snapshot: AstraZeneca Pharmaceuticals LP ($525).
Total Amount
$801
General + Research + Ownership
Payments
14
Total payment records
General Amount
$801
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-06-13
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| AstraZeneca Pharmaceuticals LP | $525 |
| Celgene Corporation | $55 |
| Amgen Inc. | $50 |
| Merck Sharp & Dohme LLC | $43 |
| Astellas Pharma US Inc | $31 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2016-08-03
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20160803002104 | I | Hematology/Oncology | MA | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 503 | 211 | $0 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | 132 | 72 | $0 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 113 | 100 | $0 |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | 32 | 22 | $0 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 29 | 29 | $0 |
Insurance plans in this area (ZIP 02703)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| Internal Medicine | RI | |
| Physician Assistant | MA | |
| Nurse Practitioner | MA | |
| - | MA | |
| O B S T E T R I C S/ G Y N E C O L O G Y | RI | |
| - | MA | |
| - | MA | |
| - | MA | |
| O B S T E T R I C S/ G Y N E C O L O G Y | RI | |
| Nurse Practitioner | MA |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.